OrphoMed, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.orphomed.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Phase 2
Completed
- Conditions
- Irritable Bowel Syndrome With Diarrhea
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- OrphoMed, Inc.
- Target Recruit Count
- 321
- Registration Number
- NCT04129619
- Locations
- 🇺🇸
Achieve Clinical Research (Site 155), Birmingham, Alabama, United States
🇺🇸Synexus Clinical Research US, Inc. - Phoenix Southeast (Site 123), Chandler, Arizona, United States
🇺🇸Elite Clinical Studies - Phoenix (Site 116), Phoenix, Arizona, United States
News
No news found